Resource

 

 

 

 

 

 

 

 

 

 

 

Banking & Finance - Capital Markets: Equity

Allen & Overy advises the Romanian electricity supplier and distributer Electrica on its successful IPO

04 Jul 2014

Allen & Overy LLP advised the formerly state-owned Romanian electricity supplier and distributer Societatea Comercialy de Distribuyie yi Furnizare a Energiei Electrice "ELECTRICA" S.A. (“Electrica”) on the dual listing and IPO of Electrica on the Bucharest and London stock exchanges.

This is the largest IPO to date in Romania and the first primary offering of shares in Romania involving global depositary receipts (“GDRs”).
 

Freshfields advises on the US$414m IPO of Jinmao Investments – Hong Kong’s fourth business trust

03 Jul 2014

Freshfields Bruckhaus Deringer has advised Jinmao Investments and Jinmao (China) Investment Holdings Limited on the global offering and listing of its share stapled units on the Hong Kong Stock Exchange.

The US$414m IPO commenced trading on the Hong Kong Stock Exchange today.

Nabarro advises Oriel Securities on IPO for £1.5bn Prestbury REIT

01 Jul 2014

Nabarro has advised Oriel Securities, a long-standing client of the firm, on the IPO of Secure Income REIT plc (Secure Income), a newly created real estate investment trust comprising well known attractions such as Madame Tussauds and Warwick Castle. Oriel Securities acted as the broker and adviser in relation to the admission to and placing of Secure Income on the London Stock Exchange’s AIM market.

Weil Advises Market-Leading UK Manufacturer Volution on its London IPO

01 Jul 2014

Weil, Gotshal & Manges advised UK manufacturer Volution Group PLC ("Volution") on its initial public offering ("IPO") on the main market of the London Stock Exchange. The IPO is the most recent in a particularly buoyant first half of 2014, with 21 IPOs on the main market, with the majority of these being private equity exits. The IPO values the equity share capital of Volution at £300 million.

Freshfields advises Spire Healthcare Group on its proposed IPO and London premium listing

30 Jun 2014

Leading International law firm, Freshfields Bruckhaus Deringer, is advising Spire Healthcare Group on its proposed IPO and London premium listing, which was announced this morning

Spire Healthcare Group is the second largest operator in the UK private independent acute healthcare sector by revenue with 39 private hospitals and 13 clinics across England, Wales and Scotland.

DLA Piper represents Parnell Pharmaceuticals in initial public offering

27 Jun 2014

DLA Piper advised Parnell Pharmaceuticals Holdings Ltd (PARN) in its initial public offering on the NASDAQ. PARN, an Australian-based veterinary pharmaceutical company with US operations located in Kansas City, Kansas, focuses on developing, manufacturing and commercializing innovative animal health solutions. The company currently markets five products for companion animals and production animals in 14 countries and augments its pharmaceutical products with its proprietary software platforms.

Hogan Lovells Advises On US$550.5 Million Placing of New H Shares of BYD Company Limited

27 Jun 2014

Hogan Lovells advised UBS AG, Hong Kong Branch ("UBS") and Deutsche Bank AG, Hong Kong Branch as the joint placing agents in respect of a placement of 121.9 million new H shares in BYD Company Limited ("BYD") for approximately HK$4.27 billion (US$550.5 million).

BYD is a leading PRC manufacturer specialising in the IT, automobile and new energy sectors. The company is one of the largest suppliers of rechargeable batteries and is the second largest producer of cell-phone shells worldwide. BYD is a listed company on the Hong Kong Stock Exchange.

Macfarlanes advises on Volution Group IPO

26 Jun 2014

Macfarlanes has advised Canaccord Genuity Limited (acting as Sponsor and Joint Bookrunner) and Liberum Capital Limited (acting as Joint Bookrunner) in connection with the London premium listing of Volution Group plc, the leading supplier of ventilation products to the residential construction market in the UK, Sweden and Germany.

Based on the offer price of 150 pence per share, which raised gross proceeds of approximately £72 million for Volution and £28 million for the selling shareholders, the market capitalisation of Volution at IPO was £300 million.

Travers Smith Acts on the £193 million IPO of Fundsmith Emerging Equities Trust plc

25 Jun 2014

Travers Smith has advised Fundsmith Emerging Equities Trust plc ("FEET") in connection with its initial public offering. FEET will invest in equities issued by companies that have the majority of their operations in, or revenues derived from, emerging economies and will seek to be directly exposed to the rise of the consumer classes in those countries.  Its launch follows an extensive roadshow to institutional and retail investors, complete with an innovative online application process.

Admission is expected to take place at 8.00 a.m. on 25 June 2014.